Shuman Zhang

Erlangen, BY 91054, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Correction: Lan et al. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer. Cancers 2022, 14, 326.

Correction: Lan et al. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer. Cancers 2022, 14, 326.

Journal: Cancers

Published: September 25, 2025

CRISPR/Cas9 Screening Highlights PFKFB3 Gene as a Major Contributor to 5-Fluorouracil Resistance in Esophageal Cancer.

CRISPR/Cas9 Screening Highlights PFKFB3 Gene as a Major Contributor to 5-Fluorouracil Resistance in Esophageal Cancer.

Journal: Cancers

Published: March 17, 2025

Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer.

Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer.

Journal: Cell death discovery

Published: December 20, 2023

Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer.

Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer.

Journal: Cancers

Published: August 18, 2023

Identification of Genes Associated with Liver Metastasis in Pancreatic Cancer Reveals PCSK6 as a Crucial Mediator.

Identification of Genes Associated with Liver Metastasis in Pancreatic Cancer Reveals PCSK6 as a Crucial Mediator.

Journal: Cancers

Published: November 08, 2022

An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer.

An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer.

Journal: Frontiers in cell and developmental biology

Published: June 22, 2022

Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer.

Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer.

Journal: Cancers

Published: May 19, 2022

CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer.

CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 09, 2022

CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer.

CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer.

Journal: Cancers

Published: December 14, 2021

Pre-clinical Models of Metastasis in Pancreatic Cancer.

Pre-clinical Models of Metastasis in Pancreatic Cancer.

Journal: Frontiers in cell and developmental biology

Published: July 28, 2021

Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting.

Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 05, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026